+906.2%
FN vs THC
+1,000.2%
-94.1%
-51.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +3.1% | +0.6% | +2.5% | +3.0% |
| 7D | -1.7% | -0.7% | -1.0% | -1.6% |
| 30D | -22.0% | +1.3% | -23.3% | -22.3% |
| 3M | -43.0% | +64.2% | -107.3% | -48.9% |
| 6M | -27.7% | +8.3% | -36.0% | -29.8% |
| YTD | -10.5% | +33.4% | -43.9% | -16.9% |
| 1Y | +12.5% | +37.7% | -25.2% | +3.5% |
| 3Y | +153.8% | +236.8% | -83.0% | +92.9% |
| 5Y | +288.0% | +249.3% | +38.7% | +183.3% |
| All | +906.2% | +1,000.2% | -94.1% | +459.8% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling